• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis).

作者信息

Mabuchi H, Michishita I, Takeda M, Fujita H, Koizumi J, Takeda R, Takada S, Oonishi M

机构信息

Second Department of Internal Medicine, Kanazawa University School of Medicine, Japan.

出版信息

Atherosclerosis. 1987 Nov;68(1-2):19-25. doi: 10.1016/0021-9150(87)90089-x.

DOI:10.1016/0021-9150(87)90089-x
PMID:2446636
Abstract

We describe a new low density lipoprotein (LDL) apheresis system using dextran sulfate cellulose column in an automated column regenerating unit (LDL continuous apheresis). Two columns containing 150 ml of dextran sulfate cellulose were used, and the whole extracorporeal circulation was about 400 ml in volume. After 600 ml of plasma was adsorbed into the first column, the second column was used as an adsorbent and meanwhile the first column was regenerated. Thus, the 2 columns were used alternately without losing the potency of the columns. As the apparatus was automatically controlled by a computerized unit, no extra manipulation is necessary compared with the conventional single-column method. By treating 4-5 liters of plasma, non-high density lipoprotein (HDL)-cholesterol levels decreased by 63-71%, and HDL-cholesterol levels remained unchanged. Thus, this new method of LDL apheresis can safely reduce LDL-cholesterol to any desired level and will be applicable for the treatment of child and adult family hypercholesterolemic patients with severe coronary heart disease.

摘要

相似文献

1
A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis).
Atherosclerosis. 1987 Nov;68(1-2):19-25. doi: 10.1016/0021-9150(87)90089-x.
2
Application of a new LDL apheresis system using two dextran sulfate cellulose columns in combination with an automatic column-regenerating unit and a blood cell separator.
J Clin Apher. 1991;6(1):11-5. doi: 10.1002/jca.2920060103.
3
Selective continuous removal of low density lipoproteins by dextran sulfate cellulose column adsorption apheresis in the therapy of familial hypercholesterolemia.在家族性高胆固醇血症治疗中,通过硫酸葡聚糖纤维素柱吸附单采法选择性连续去除低密度脂蛋白。
Beitr Infusionsther. 1988;23:172-82.
4
Efficacy and safety measures for low density lipoprotein apheresis treatment using dextran sulfate cellulose columns.使用硫酸葡聚糖纤维素柱进行低密度脂蛋白分离治疗的疗效和安全措施。
Ther Apher. 1999 May;3(2):155-60. doi: 10.1111/j.1526-0968.1999.00160.pp.x.
5
Long-term experience with extracorporeal low-density lipoprotein cholesterol removal by dextran sulfate cellulose adsorption.
Clin Investig. 1992 Feb;70(2):99-104. doi: 10.1007/BF00227348.
6
Effect of continuous LDL apheresis with dextran-sulfate cellulose column system on a child with homozygous familial hypercholesterolemia.
Acta Paediatr Jpn. 1990 Apr;32(2):146-50. doi: 10.1111/j.1442-200x.1990.tb00800.x.
7
[Changes in serum lipids and lipoproteins in 3 cases of heterozygous familial hypercholesterolemia treated by LDL apheresis on dextran sulfate-cellulose columns].[3例杂合子家族性高胆固醇血症患者经硫酸葡聚糖-纤维素柱低密度脂蛋白分离置换法治疗后血清脂质和脂蛋白的变化]
Ann Med Interne (Paris). 1988;139 Suppl 1:80-2.
8
Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia.
Atherosclerosis. 1993 Apr;100(1):65-74. doi: 10.1016/0021-9150(93)90068-6.
9
Changes in coagulation factors by passage through a dextran sulfate cellulose column during low-density lipoprotein apheresis.
Int J Artif Organs. 1992 Mar;15(3):185-90.
10
The first results demonstrating efficiency and safety of a double-column whole blood method of LDL-apheresis.首次结果证明了双柱全血法低密度脂蛋白去除术的有效性和安全性。
Transfus Apher Sci. 2010 Feb;42(1):3-10. doi: 10.1016/j.transci.2009.10.001. Epub 2009 Nov 20.

引用本文的文献

1
Lipoprotein Apheresis: Current Recommendations for Treating Familial Hypercholesterolemia and Elevated Lipoprotein(a).脂蛋白吸附治疗:家族性高胆固醇血症和脂蛋白(a)升高的治疗推荐。
Curr Atheroscler Rep. 2023 Jul;25(7):391-404. doi: 10.1007/s11883-023-01113-2. Epub 2023 Jun 5.
2
Current Role of Lipoprotein Apheresis.脂蛋白吸附术的当前作用。
Curr Atheroscler Rep. 2019 May 1;21(7):26. doi: 10.1007/s11883-019-0787-5.
3
Lipoprotein apheresis in the management of familial hypercholesterolaemia: historical perspective and recent advances.
脂蛋白吸附疗法在家族性高胆固醇血症治疗中的应用:历史回顾与最新进展。
Curr Atheroscler Rep. 2015 Jan;17(1):465. doi: 10.1007/s11883-014-0465-6.
4
LDL-apheresis: technical and clinical aspects.低密度脂蛋白分离术:技术与临床方面
ScientificWorldJournal. 2012;2012:314283. doi: 10.1100/2012/314283. Epub 2012 Apr 30.
5
Current view: indications for extracorporeal lipid apheresis treatment.当前观点:体外脂质吸附治疗的适应症
Clin Res Cardiol Suppl. 2012 Jun;7(Suppl 1):15-9. doi: 10.1007/s11789-012-0046-6.
6
Low-density lipoprotein apheresis reduces platelet factor 4 on the surface of platelets: a possible protective mechanism against heparin-induced thrombocytopenia and thrombosis.低密度脂蛋白吸附术降低血小板表面的血小板因子 4:肝素诱导的血小板减少症和血栓形成的一种可能保护机制。
Transfusion. 2011 May;51(5):1022-9. doi: 10.1111/j.1537-2995.2010.02911.x. Epub 2010 Oct 26.
7
Plasminogen activator inhibitor-1 removal using dextran sulphate columns. Evidence of PAI-1 homeostasis.使用硫酸葡聚糖柱去除纤溶酶原激活物抑制剂-1。PAI-1稳态的证据。
J Thromb Thrombolysis. 2009 Aug;28(2):166-72. doi: 10.1007/s11239-008-0260-8. Epub 2008 Jul 30.
8
LDL-apheresis therapy.低密度脂蛋白单采术治疗
Curr Treat Options Cardiovasc Med. 2006 Aug;8(4):282-8. doi: 10.1007/s11936-006-0049-z.
9
The effect of plasma low density lipoprotein apheresis on the hepatic secretion of biliary lipids in humans.血浆低密度脂蛋白去除术对人体肝脏胆汁脂质分泌的影响。
Gut. 1997 Nov;41(5):700-4. doi: 10.1136/gut.41.5.700.
10
Antioxidant status of hypercholesterolemic patients treated with LDL apheresis.
Cardiovasc Drugs Ther. 1996 Nov;10(5):567-71. doi: 10.1007/BF00050998.